Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial
- PMID: 18156639
- PMCID: PMC2632488
- DOI: 10.1093/schbul/sbm138
Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial
Abstract
Objective: The effects of estrogen on comprehension of metaphoric speech, word fluency, and verbal ability were investigated in women suffering from schizophrenia. The issue of estrogen-dependent neuropsychological performance could be highly relevant because women with schizophrenia frequently suffer from hypoestrogenism.
Method: A placebo-controlled, double-blind, crossover study using 17beta-estradiol for replacement therapy and as an adjunct to a naturalistic maintenance antipsychotic treatment was carried out over a period of 8 months. Nineteen women (mean age = 38.0 years, SD = 9.9 years) with schizophrenia were included in the study. Comprehension of metaphoric speech was measured by a lexical decision paradigm, word fluency, and verbal ability by a paper-and-pencil test.
Results: Significant improvement was seen for the activation of metaphoric meaning during estrogen treatment (P = .013); in contrast, no difference was found for the activation of concrete meaning under this condition. Verbal ability and word fluency did not improve under estrogen replacement therapy either.
Conclusions: This is the very first study based on estrogen intervention instead of the physiological hormone changes to examine the estrogen effects on neuropsychological performance in women with schizophrenia. In addition, it is the first time that the effect of estrogen on metaphoric speech comprehension was investigated in this context. While in a previous study estrogen therapy as adjunct to a naturalistic maintenance treatment with antipsychotics did not show an effect on psychopathology measured by a rating scale, a significant effect of estrogen on the comprehension of metaphoric speech and/or concretism, a main feature of schizophrenic thought and language disturbance, was found in the present study. Because the improvement of formal thought disorders and language disturbances is crucial for social integration of patients with schizophrenia, the results may have implications for the treatment of these individuals.
Similar articles
-
Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled study.Psychoneuroendocrinology. 2008 May;33(4):507-16. doi: 10.1016/j.psyneuen.2008.01.009. Epub 2008 Mar 14. Psychoneuroendocrinology. 2008. PMID: 18343039 Clinical Trial.
-
[Comprehension of metaphoric speech by healthy probands and schizophrenic patients. An experimental psychopathologic contribution to concretism].Nervenarzt. 1994 May;65(5):282-92. Nervenarzt. 1994. PMID: 8052330 German.
-
Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.J Clin Psychopharmacol. 2006 Oct;26(5):495-9. doi: 10.1097/01.jcp.0000237942.50270.35. J Clin Psychopharmacol. 2006. PMID: 16974191 Clinical Trial.
-
Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.Arch Gen Psychiatry. 2005 Sep;62(9):961-70. doi: 10.1001/archpsyc.62.9.961. Arch Gen Psychiatry. 2005. PMID: 16143728 Review.
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
Cited by
-
A Multimodal Speech-Gesture Training Intervention for Patients With Schizophrenia and Its Neural Underpinnings - the Study Protocol of a Randomized Controlled Pilot Trial.Front Psychiatry. 2020 Mar 6;11:110. doi: 10.3389/fpsyt.2020.00110. eCollection 2020. Front Psychiatry. 2020. PMID: 32210849 Free PMC article.
-
Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia.Schizophr Res. 2015 Aug;166(1-3):269-75. doi: 10.1016/j.schres.2015.04.039. Epub 2015 May 16. Schizophr Res. 2015. PMID: 25990704 Free PMC article.
-
Superior temporal sulcus disconnectivity during processing of metaphoric gestures in schizophrenia.Schizophr Bull. 2014 Jul;40(4):936-44. doi: 10.1093/schbul/sbt110. Epub 2013 Aug 16. Schizophr Bull. 2014. PMID: 23956120 Free PMC article.
-
Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments.Int J Mol Sci. 2021 Sep 14;22(18):9905. doi: 10.3390/ijms22189905. Int J Mol Sci. 2021. PMID: 34576069 Free PMC article. Review.
-
The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders.Int J Mol Sci. 2020 Dec 31;22(1):373. doi: 10.3390/ijms22010373. Int J Mol Sci. 2020. PMID: 33396472 Free PMC article. Review.
References
-
- Hampson E. Sex differences in human brain and cognition: the influence of sex steroids in early and adult life. In: Becker JB, Breedlove SM, Crews D, McCarthy MM, editors. Behavioral Endocrinology. 2nd ed. Cambridge, Mass: MIT Press; 2002. pp. 579–628.
-
- Halbreich U, Lumley LA. The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J Affect Disord. 1993;29:159–173. - PubMed
-
- Sherwin BB. Estrogen and cognitive functioning in women. Proc Soc Exp Biol Med. 1998;217:17–22. - PubMed
-
- Fink G, Sumner BEH, McQueen JK, Wilson H, Rosie R. Sex steroids control of mood, mental state and memory. Clin Exp Pharmacol Physiol. 1998;25:764–775. - PubMed
-
- Norbury R, Craig M, Cutter WJ, Whitehead M, Murphy DGM. Oestrogen: brain ageing, cognition and neuropsychiatric disorder. J Br Menopause Soc. 2004;10:118–122. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical